Average Co-Inventor Count = 6.60
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Berlex Laboratories, Inc. (15 from 100 patents)
2. Bristol-myers Squibb Compnay (13 from 3,681 patents)
3. Jn Therapeutics (1 from 1 patent)
29 patents:
1. 10730875 - Substituted imidazo[1,2-A]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
2. 10023519 - Cyclobutane containing carboxylic acid GPR120 modulators
3. 9938222 - Cyclopropanecarboxylic acid GPR120 modulators
4. 9518000 - Bicyclo [2.2.1] acid GPR120 modulators
5. 8962660 - Oxabicyclo [2.2.2] acid GPR120 modulators
6. 8318941 - Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
7. 7951793 - Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
8. 7326705 - Heterocyclic sodium/proton exchange inhibitors and method
9. 7279485 - Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10. 6887870 - Heterocyclic sodium/proton exchange inhibitors and method
11. 6713467 - Acid derivatives useful as serine protease inhibitors
12. 6686364 - Benzamidine derivatives and their use as anti-coagulants
13. 6642252 - Acid derivatives useful as serine protease inhibitors
14. 6498185 - Ortho-anthranilamide derivatives as anti-coagulants
15. 6479485 - Benzamidine derivatives and their use as anti-coagulants